| Literature DB >> 35775421 |
Sara Jm Laurijssen1, Rieke van der Graaf2, Wouter B van Dijk2, Ewoud Schuit2, Rolf Hh Groenwold3, Diederick E Grobbee2, Martine C de Vries1.
Abstract
BACKGROUND: Informed consent is one of the cornerstones of biomedical research with human subjects. Research ethics committees may allow for a modification or a waiver of consent when the research has social value, involves minimal risk, and if consent is impractical to obtain. While the conditions of social value and minimal risk have received ample attention in research ethics literature, the impractical condition remains unclear. There seem to be different interpretations of the meaning of impractical within academic literature. To address this lack of clarity, we performed a systematic review on the interpretation of impractical.Entities:
Keywords: Impracticable; impossible; infeasible; informed consent; modification; waiver
Mesh:
Year: 2022 PMID: 35775421 PMCID: PMC9523816 DOI: 10.1177/17407745221103567
Source DB: PubMed Journal: Clin Trials ISSN: 1740-7745 Impact factor: 2.599
Figure 1.Initial search.
Search string PubMed: ((“informed consent”) AND (impracticable OR infeasible OR impossible OR “not possible” OR “not feasible” OR “not practical”)).
Search string Embase: ((exp Informed Consent/or informed consent.ti.) and (impracticable or impractic* or infeasible or infeasib* or unfeasible or unfeasib* or impossible or impossib* or possible or feasible or practical).ti.) not (conference review or conference abstract).pt.
Search string Web of Science: ((ALL = ((“Informed Consent” OR “informed consent” OR “consent*”) AND (“impracticable” OR “impractic*” OR “infeasible” OR “infeasib*” OR “unfeasible” OR “unfeasib*” OR “impossible” OR “impossib*” OR “not possible” OR “not feasible” OR “not practical”)))) AND LANGUAGE: (English) AND DOCUMENT TYPES: (Article) Indexes = SCI-EXPANDED, SSCI, A&HCI, ESCI Timespan = 1945–2020.
Figure 2.Second search.
Search string PubMed: ((“Informed Consent”[Mesh] OR “informed consent”[tw] OR “consent*”[ti]) AND (“impracticable”[tw] OR “impractic*”[tw] OR “infeasible”[tw] OR “infeasib*”[tw] OR “unfeasible”[tw] OR “unfeasib*”[tw] OR “impossible”[tw] OR “impossib*”[tw] OR “not possible”[tw] OR “not feasible”[tw] OR “not practical”[tw] OR “difficult circumstances”[tw] OR “difficult circumstanc*”[tw] OR “large number”[tw] OR “large number of participants”[tw] OR “violating privacy” [tw] OR “generalizability”[tw] OR “low response rate”[tw] OR “high costs”[tw] OR “time pressure”[tw] OR “time pressur*”[tw] OR “scientific value”[tw] OR “difficult situation*”[tw])).
Search string EMBASE: ((exp Informed Consent/ or informed consent.ti.) and (impracticable.ti. or impractic*.ti. or infeasible.ti. or infeasib*.ti. or unfeasible.ti. or unfeasib*.ti. or impossible.ti. or impossib*.ti. or possible.ti. or feasible.ti. or practical.ti. or difficult circumstances.ti. or difficult circumstanc*.ti. or large number.ti. or large number of participants.ti. or time pressure.ti. or time pressur*.ti. or difficult situation*.ti. or violating privacy.ti. or generalizability.ti. or low response rate.ti. or high costs.ti. or time pressure.ti. or time pressur*.ti. OR scientific value.ti. or difficult situation*.ti.)) NOT (conference review or conference abstract).pt.
Search string Web of Science: (ALL = ((“Informed Consent” OR “informed consent” OR “consent*”) AND (“impracticable” OR “impractic*” OR “infeasible” OR “infeasib*” OR “unfeasible” OR “unfeasib*” OR “impossible” OR “impossib*” OR “not possible” OR “not feasible” OR “not practical”))).
Usage of impractical in research ethics guidelines.
| Guideline | Description of impractical related to a waiver or a modification of informed consent |
|---|---|
| Council for International Organizations of Medical Sciences (CIOMS)—2016 International Ethical Guidelines for Health-related Research Involving Humans | “A research ethics committee may approve a modification or waiver of informed consent to research if: the research would not be feasible or practicable to carry out without the waiver or modification; the research has important social value; and the research poses no more than minimal risks to participants.” |
| The Declaration of Helsinki (2013) | “32. For medical research using identifiable human material or data, such as research on material or data contained in biobanks or similar repositories, physicians must seek informed consent for its collection, storage and/or reuse. There may be exceptional situations where consent would be impossible or impractical to obtain for such research. In such situations the research may be done only after consideration and approval of a research ethics committee.” |
| Belmont Report (2013) | – |
| Council of Europe’s Convention on Human Rights and Biomedicine (1997) | – |
| UNESCO’s Universal Declaration on Bioethics and Human Rights (2005) | “2. Scientific research should only be carried out with the prior, free, express and informed consent of the person concerned. The information should be adequate, provided in a comprehensible form and should include modalities for withdrawal of consent. Consent may be withdrawn by the person concerned at any time and for any reason without any disadvantage or prejudice. Exceptions to this principle should be made only in accordance with ethical and legal standards adopted by States, consistent with the principles and provisions set out in this Declaration, in particular in Article 27, and international human rights law.” |
| Nuremberg Code (2007) | – |
| European Union’s General Data Protection Regulation (2016) | “Article 14 Information to be provided where personal data have not been obtained from the data subject 1. Where personal data have not been obtained from the data subject, the controller shall provide the data subject with the following information […]5. Paragraphs 1 to 4 shall not apply where and insofar as: (a) the data subject already has the information; (b) the provision of such information proves impossible or would involve a disproportionate effort, in particular for processing for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes, subject to the conditions and safeguards referred to in Article 89(1) or in so far as the obligation referred to in paragraph 1 of this Article is likely to render impossible or seriously impair the achievement of the objectives of that processing. In such cases the controller shall take appropriate measures to protect the data subject’s rights and freedoms and legitimate interests, including making the information publicly available; (c) obtaining or disclosure is expressly laid down by Union or Member State law to which the controller is subject and which provides appropriate measures to protect the data subject’s legitimate interests; or (d) where the personal data must remain confidential subject to an obligation of professional secrecy regulated by Union or Member State law, including a statutory obligation of secrecy.” |
| United States Common Rule (2018) | “(3) Requirements for waiver and alteration. In order for an IRB to waive or alter consent as described in this subsection, the IRB must find and document that: |
Overview of the articles.
| References | Country | Paper type | Scope of paper | Aim of paper | Terms used |
|---|---|---|---|---|---|
| 1. Ballantyne | New Zealand | Opinion | Research ethics, health data | To show that a research ethics approach leads to a primary focus on individual patient consent and control of data and to show how a public health ethics lens shifts the focus to collective interests and provides for richer debate about power, justice and equity in health data research. | Impractical/impossible |
| 2. Ballantyneand Moore | New Zealand | Opinion | Research ethics,health data | To assess how New Zealand research ethics committees weigh the potentially competing goals of enabling research and protecting patients’ rights. | Impractical/impossible |
| 3. Ballantyneand Schaefer | New Zealand | Opinion | Researchethics, health data | To argue that a moral duty to participate in research can ground waivers of informed consent for secondary research using public sector health data, even when obtaining such consent would be practicable. | Impractical/impossible |
| 4. Ballantyneand Schaefer | New Zealand | Opinion | Researchethics, health data | To argue that “public interest” best reflects the normative work required to justify consent waivers. | Impractical |
| 5. Ballantyne et al. | New Zealand | Opinion | Research ethics, health data | To demonstrate the different ways researchers and research ethics committees analyze ethical questions about tissue and data research. This study is important because it demonstrates where researchers and RECs are talking past each other. | Impractical |
| 6. Bateman et al. | The Unites States | Opinion | Stroke research | To bring the current regulations to the attention of stroke researchers and to explore their application to the conduct of acute stroke research. | Impossible |
| 7. Bathe andMcGuire | Canada | Commentary | Research ethics,genome research | To define an ethical framework for accessing archival tissues, taking into account the needs of the research community, as well as the rights and expectations of participants. | Impractical |
| 8. Biros et al. | The Unites States | Consensusstatement | Emergency research | To present consensus recommendation for regulatory changes for consent in emergency research. | Impractical/impossible |
| 9. Chen et al. | The Unites States | Case study | Genetics | To explore whether a waiver of consent with notification and the option to withdraw (WNOW) is a viable alternative to written informed consent for secondary uses of samples and data. | Impractical |
| 10. Clifton et al. | The Unites States | Researchreport | Acute brain injury | To determine the effect of consent mechanism on the conduct of one study of emergency therapy in severe brain injury, the investigators compared the data from the 392 patients who were enrolled in NABISH showing (1) the relative accrual rates, (2) the time to experimental treatment, and (3) the rates of enrollment of minorities, non-minorities, and the poor in the time period when randomization was conducted only with prospective, informed consent and in the period when waiver of consent was used in conjunction with prospective, informed consent. | Not practical |
| 11. Colledge and Elger | Switzerland | Analysis | Bio-preservationand biobanking | To examine the implications of paragraph 25 of the Declaration of Helsinki and assess its role in the debates on proper sample handling. | Impossible/impractical/threat to validity |
| 12. Dickert and Kass | The Unites States | Opinion | Emergency research | To deepen knowledge of how a significant and previously unstudied population—survivors of sudden cardiac death—view research in emergency settings without informed consent. | Impossibleimpractical |
| 13. Di Iorio et al. | Italy | Opinion | Data research | To give an in-depth review of the Draft Report of the European Parliament Committee on Civil Liberties, Justice and Home Affairs and their implications for health research and statistics, should they stand as written. | Impossible/impractical |
| 14. Drepper | Germany | Opinion | Data ethics | To argue that The European General Data Protection Regulation (GDPR) incorporates many of the principles of data protection that were already in force in the past. | Impractical/impossible |
| 15. Flory et al. | The Unites States | Review | Informed consent | To conduct a narrative review with the goal of providing evidence and conceptual frameworks for future research and policy regarding randomization without consent. | Infeasible/impossible |
| 16. Fox et al. | The Unites States | Research report | Trauma acute care surgeon | To examine the rationale and tradeoffs of using waiver of consent in the PRospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study. | Not possible |
| 17. Gallo et al. | Canada | Opinion | Trials | To outline the development of the use of gatekeepers in the CRT literature. To document the wide variety of roles served by gatekeepers in the protection of individual, cluster, and organizational interests in CRTs. To provide a detailed ethical analysis of the authority of gatekeepers to fulfill these roles legitimately. Fourth, and finally, we consider the application of our findings using three examples. | Impossible/infeasible |
| 18. Gelinas et al. | The Unites States | Opinion | Research ethics | To determine when and why clinical research without consent is permissible. | Impractical/unfeasible |
| 19. George et al. | The United Kingdom | Research report | Consent in labor research | To obtain the views of parturients on the appropriateness, need, and timing for consent for such intrapartum research, so that their views could inform the debate. | Impossible/impractical/unreasonable |
| 20. Giraudeau et al. | France | Review | Cluster randomized trials | To assess whether participant’s informed consent was required, the nature of the consent, and whether partial information had been delivered to included participants to help prevent bias. | Impossible |
| 21. Halila | Finland | Opinion | Emergency research | To assess different ethical arguments concerning informed consent in emergency research. | Impossible |
| 22. London et al. | Canada | Opinion | Ethics; stepped-wedge trials | To consider whether and when ethical review is required for stepped-wedge trials. | Infeasible |
| 23. Holman | Australia | Commentary | Methods and ethics | To argue for the impracticability to seek informed consent for use of linked health records. | Impractical |
| 24. Jansen et al. | The Netherlands | Research report | Legal and ethical issues in intensive care medicine | To compare the results of a recent randomized controlled multicentre study in the field of intensive care medicine. | Impossible |
| 25. Kalkman et al. | The Netherlands | Opinion | Pragmatic trials | To argue that there are salient differences between pragmatic trials, especially between premarket EPTs and pragmatic trials with standard-of-care treatments, and delineate their implications for the obligation to seek informed consent from trial participants. | Impractical |
| 26. Kalkman et al. | The Netherlands | Opinion | Pragmatic trials | To analyze claims about the challenges that traditional informed consent procedures might pose to the practicability of pragmatic trials. Subsequently, the article discusses four alternative informed consent procedures proposed in response to these claims. | Impractical/impossible |
| 27. Kirchhoffer and Dierickx | Australia | Opinion | Biobanking | To address the role that the concept of human dignity might play in ethical and legal reflections on the notion of informed consent in research biobanking. | Impossible |
| 28. Lertsithichai | Thailand | Opinion | Observational research | To review the requirements for waivers of informed consent in clinical research on participants who are patients in a hospital. | Impractical |
| 29. Lignou | The United Kingdom | Opinion | Research ethics | To discuss different types of health research employed by the cluster design where informed consent is problematic. | Infeasible/impossible |
| 30. London et al. | The United Kingdom/Canada | Opinion | Ethics; cluster—cluster trials | To provide guidance for researchers and research ethics committees for avoiding the improper use of waivers of consent in individual-cluster trials. | Impractical/infeasible/impossible |
| 31. Maitland et al.(2011) | The United Kingdomand Kenya | Review | Consent in emergencyresearch trials | To consider two important practical and ethical aspects of the consent process: community consultation, and alternatives to prior full written consent among populations with diminished autonomy. | Impossible/impractical |
| 32. McGuire and Beskow | The Unites States | Opinion | Genetic research ethics | To discuss the challenge of informed consent in genetic research, explore specific elements of informed consent for genetic and genomic research, and consider alternative consent models that have been proposed. | Impossible |
| 33. McRae et al. | Canada | Opinion | Ethical issues in cluster randomized trials | To answer the question of from whom, when, and how must informed consent be obtained in CRTs in health research? | Impractical/impossible/infeasible |
| 34. Mentzelopoulos et al. | Greece | Review article | European Union Legislation | To review the changes in EU legislation and their impact on EU emergency research. | Impossible |
| 35. Morgans | Australia | Opinion | Emergency health research | To explore the issues of informed consent for research in emergency health situations. | Impractical/not feasible |
| 36. Morris | The Unites States | Ethical Analysis | Informed consent | To argue that certain exceptions to informed consent provide an ethical means to advance the science of resuscitation. | Infeasible |
| 37. Schmit et al. | The Unites States | Delphi study | Internet research | To improve communication with patients and transparency about how complex software, such as MiNDFIRL, is used to enhance privacy in secondary database studies to maintain the public’s trust in researchers. | |
| 38. Takala | Finland | Opinion | Medical law | To argue that there are two reasons why we should be very cautious about relaxing some of the key ethical rules such as “consent” and “confidentiality” simply to facilitate more efficient genetic research. | Impractical |
| 39. Tu et al. | Canada | Opinion | Electronic health record research | To examine the effectiveness of the attempt to obtain consent for participation in the registry during its first 2 years of operation and describe the challenges and limitations that arose as a result. | Impractical |
| 40. Van der Baan et al. | The Netherlands | Research report | Psychiatric biobanks | To contribute to the future organization of psychiatric hospitals, in which samples are stored and research is enabled in an ethically justifiable way. | Impractical |
| 41. Wallis et al. | New Zealand/Ireland | Review | Electronic health record research | To investigate if research using personal health information without consent risks damaging the doctor–patient relationship. | Not feasible |
| 42. Watanabe et al. | Japan | Opinion | Biobanking | To introduce methods used to communicate with participants in the “Biobank Japan Project (BBJP)”, which is a disease-focused biobanking project. | Impossible |
CRT = cluster randomized trial; EPTs= be early pragmatic trials; RECs= research ethics committee; NABISH= National Acute Brain Injury Study: Hypothermia.
Usage of impractical.
| Categories | Types of research | Interpretations of impractical |
|---|---|---|
| 1. Obtaining informed consentbecomes too demanding on researchers | Electronic health record research | Large sample size |
| 2. Obtaining informed consent leads to invalid study outcomes | Electronic health record research | Selection bias |
| 3. Obtaining informed consent harms the participant | Biobank research | Violation of privacy |
| 4. Obtaining informed consent ismeaningless for the participant(informed consent has no value for the participant) | Biobank research | Future research objectives are unknown |